Organigram Global Inc. (TSX:OGI)
0.9000
-0.0600 (-6.25%)
Nov 19, 2026, 4:00 PM EST
Organigram Global Revenue
Organigram Global had revenue of 105.78M CAD in the quarter ending June 30, 2026, with 49.43% growth. This brings the company's total for the last twelve months to 309.18M, up 38.14% year-over-year. In the fiscal year ending September 30, 2025, Organigram Global had annual revenue of 259.18M with 62.15% growth. That makes Organigram Global the 16,977th largest company in the world by revenue and 346th in Canada.
Revenue (ttm)
309.18M
Revenue Growth
+38.14%
P/S Ratio
0.42
Revenue / Employee
271.44K
Employees
1,120
Market Cap
126.91M
Revenue by Geography
- Canada 376.55M 93.5%
- International 26.34M 6.5%
Fiscal year ended Sep 30, 2025 See the full Organigram Global breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 259.18M | 99.34M | 62.15% |
| Sep 30, 2024 | 159.84M | -1.80M | -1.11% |
| Sep 30, 2023 | 161.64M | 15.83M | 10.86% |
| Aug 31, 2022 | 145.81M | 66.65M | 84.19% |
| Aug 31, 2021 | 79.16M | -7.63M | -8.79% |
| Aug 31, 2020 | 86.80M | 6.38M | 7.94% |
| Aug 31, 2019 | 80.41M | 67.98M | 546.98% |
| Aug 31, 2018 | 12.43M | -377.00K | -2.94% |
| Aug 31, 2017 | 12.81M | 550.75K | 4.49% |
| Aug 31, 2016 | 12.26M | 11.27M | 1,142.07% |
| Aug 31, 2015 | 986.68K | - | - |
| Feb 28, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cresco Labs | 924.67M |
| Ascend Wellness Holdings | 700.76M |
| TerrAscend | 379.07M |
| Medexus Pharmaceuticals | 152.84M |
| Decibel Cannabis Company | 127.08M |
| Cannara Biotech | 117.33M |
| HLS Therapeutics | 80.76M |
| Grown Rogue International | 57.07M |
Organigram Global News
- 5 days ago - Organigram receives Nasdaq notice of non-compliance - TheFly
- 5 days ago - Organigram Provides NASDAQ Listing Update - Business Wire
- 10 days ago - The Big Winner From the Aurora Cannabis-Organigram Deal: Curaleaf - The Motley Fool
- 13 days ago - Aurora Cannabis Announces Fiscal 2027 Second Quarter Results and Organigram Acquisition Agreement - Nasdaq
- 15 days ago - Aurora Cannabis Inc. Enters into Arrangement Agreement to be Acquired by Organigram Global Inc. for C$7.80 Per Share - Nasdaq
- 16 days ago - Organigram to Acquire Aurora Cannabis Inc. for C$7.80 Per Share - Nasdaq
- 16 days ago - Organigram signs friendly deal to buy Edmonton-based Aurora Cannabis after hostile Curaleaf offer - CBC News
- 16 days ago - Organigram To Acquire Aurora Cannabis In C$561 Mln Deal - Nasdaq